Skip to content
PubMed This is a summary of 49 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 49 referenced papers

Top Authors

Bianca Maria Rotoli
University of Parma
Valeria Dall’Asta
University of Parma
Nasreen Lalani
Purdue University West Lafayette
Andrea Gropman
Children's National
Johanna Kurko
University of Turku
Juha Mykkänen
University of Turku
Freddie Bray
Centre international de recherche sur le cancer
Joanne Olson
University of Alberta
Wendy Duggleby
University of Alberta
Amelia Barilli
University of Parma

Top Institutions

Ranked by publications Top 10 institutions
09

Centre international de recherche sur le cancer

Lyon, France

3 papers

References

References (49)
  1. 1

    Urine Beta2-Microglobulin Is an Early Marker of Renal Involvement in LPI.

    Kärki M, Näntö-Salonen K, Niinikoski H, Tanner LM

    JIMD reports 2016; (25()):47-55 doi:10.1007/8904_2015_465.

    PMID: 26122628
  2. 2

    Dysfunction in macrophage toll-like receptor signaling caused by an inborn error of cationic amino acid transport.

    Kurko J, Vähä-Mäkilä M, Tringham M, et al.

    Molecular immunology 2015; (67(2 Pt B)):416-25.

    PMID: 26210182
  3. 3

    Renal Involvement in a French Paediatric Cohort of Patients with Lysinuric Protein Intolerance.

    Nicolas C, Bednarek N, Vuiblet V, et al.

    JIMD reports 2016; (29()):11-17 doi:10.1007/8904_2015_509.

    PMID: 26608393
  4. 4

    Clinical and genetic features of lysinuric protein intolerance in Japan.

    Noguchi A, Nakamura K, Murayama K, et al.

    Pediatrics international : official journal of the Japan Pediatric Society 2016; (58(10)):979-983 doi:10.1111/ped.12946.

    PMID: 26865117
  5. 5

    Imbalance of plasma amino acids, metabolites and lipids in patients with lysinuric protein intolerance (LPI).

    Kurko J, Tringham M, Tanner L, et al.

    Metabolism: clinical and experimental 2016; (65(9)):1361-75.

    PMID: 27506743
  6. 6

    Lysinuric Protein Intolerance Presenting with Recurrent Hyperammonemic Encephalopathy.

    Bijarnia-Mahay S, Jain V, Bansal RK, et al.

    Indian pediatrics 2016; (53(8)):732-4 doi:10.1007/s13312-016-0920-2.

    PMID: 27567650
  7. 7

    Congenital Pulmonary Alveolar Proteinosis: From Birth to Ten-years of Age.

    Alavuk Kundović S, Popović L

    Indian journal of pediatrics 2017; (84(9)):721-723 doi:10.1007/s12098-017-2365-6.

    PMID: 28512724
  8. 8

    Lysinuric protein intolerance in a family of Mexican ancestry with a novel SLC7A7 gene deletion. Case report and review of the literature.

    Carpentieri D, Barnhart MF, Aleck K, et al.

    Molecular genetics and metabolism reports 2015; (2()):47-50 doi:10.1016/j.ymgmr.2014.12.005.

    PMID: 28649527
  9. 9

    Successful haematopoietic stem cell transplantation in a case of pulmonary alveolar proteinosis due to GM-CSF receptor deficiency.

    Frémond ML, Hadchouel A, Schweitzer C, et al.

    Thorax 2018; (73(6)):590-592 doi:10.1136/thoraxjnl-2017-211076.

    PMID: 29263235
  10. 10

    Hyperammonemia in a Child Presenting with Growth Delay, Short Stature, and Diarrhea.

    Almontashiri NAM, Demirbas D, Berry GT, Peake RWA

    Clinical chemistry 2018; (64(8)):1260-1262 doi:10.1373/clinchem.2018.291146.

    PMID: 30054302
  11. 11

    The utility of EEG monitoring in neonates with hyperammonemia due to inborn errors of metabolism.

    Wiwattanadittakul N, Prust M, Gaillard WD, et al.

    Molecular genetics and metabolism 2018; (125(3)):235-240 doi:10.1016/j.ymgme.2018.08.011.

    PMID: 30197275
  12. 12

    Acute Presentation and Management of the Encephalopathic Child With an Undiagnosed Inborn Error of Metabolism.

    Bennett EE, Hummel K, Smith AG, Longo N

    The Journal of emergency medicine 2019; (56(1)):e5-e8 doi:10.1016/j.jemermed.2018.09.037.

    PMID: 30420308
  13. 13

    Nutrition process improvements for adult inpatients with inborn errors of metabolism using the i-PARIHS framework.

    Williams C, van der Meij BS, Nisbet J, et al.

    Nutrition & dietetics : the journal of the Dietitians Association of Australia 2019; (76(2)):141-149 doi:10.1111/1747-0080.12517.

    PMID: 30848058
  14. 14

    [Clinical features of children with lysinuric protein intolerance and SLC7A7 gene mutation: an analysis of 3 cases].

    Cui D, Hu YH, Tang G, et al.

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2019; (21(4)):375-380.

    PMID: 31014432
  15. 15

    Rise Above: Experiences of Spirituality Among Family Caregivers Caring for Their Dying Family Member in a Hospice Setting in Pakistan.

    Lalani N, Duggleby W, Olson J

    Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association 2019; (21(5)):422-429 doi:10.1097/NJH.0000000000000584.

    PMID: 31318734
  16. 16

    Lysinuric protein intolerance with homozygous SLC7A7 mutation caused by maternal uniparental isodisomy of chromosome 14.

    Kang E, Kim T, Oh A, et al.

    Journal of human genetics 2019; (64(11)):1137-1140 doi:10.1038/s10038-019-0657-6.

    PMID: 31427715
  17. 17

    Inducible Slc7a7 Knockout Mouse Model Recapitulates Lysinuric Protein Intolerance Disease.

    Bodoy S, Sotillo F, Espino-Guarch M, et al.

    International journal of molecular sciences 2019; (20(21)) doi:10.3390/ijms20215294.

    PMID: 31653080
  18. 18

    y+LAT1 and y+LAT2 contribution to arginine uptake in different human cell models: Implications in the pathophysiology of Lysinuric Protein Intolerance.

    Rotoli BM, Barilli A, Visigalli R, et al.

    Journal of cellular and molecular medicine 2020; (24(1)):921-929 doi:10.1111/jcmm.14801.

    PMID: 31705628
  19. 19

    Pearls & Oy-sters: Chemotherapy-associated hyperammonemic encephalopathy.

    Neves Briard J, Lezaic N, Keezer MR

    Neurology 2020; (94(8)):e874-e877 doi:10.1212/WNL.0000000000009004.

    PMID: 31992681
  20. 20

    Heterogeneous colonic content: A prenatal sonographic manifestation of lysinuric protein intolerance.

    Dimitriou C, Saliba S, Peyrassol X, et al.

    Clinical case reports 2020; (8(6)):1010-1014 doi:10.1002/ccr3.2780.

    PMID: 32577254
  21. 21

    Lysinuric protein intolerance: Pearls to detect this otherwise easily missed diagnosis.

    Alqarajeh F, Omorodion J, Bosfield K, et al.

    Translational science of rare diseases 2020; (5(1-2)):81-86 doi:10.3233/TRD-190035.

    PMID: 33134088
  22. 22

    Lysinuric protein intolerance mimicking N-acetylglutamate synthase deficiency in a nine-year-old boy.

    Al-Qattan S, Malcolmson C, Mercimek-Andrews S

    Molecular genetics and metabolism reports 2021; (27()):100741 doi:10.1016/j.ymgmr.2021.100741.

    PMID: 33763330
  23. 23

    The utility of reverse phenotyping: a case of lysinuric protein intolerance presented with childhood osteoporosis.

    Avci Durmusalioglu E, Isik E, Ayyildiz Emecen D, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2021; (34(7)):957-960 doi:10.1515/jpem-2021-0018.

    PMID: 33823103
  24. 24

    Immune Dysregulation Mimicking Systemic Lupus Erythematosus in a Patient With Lysinuric Protein Intolerance: Case Report and Review of the Literature.

    Contreras JL, Ladino MA, Aránguiz K, et al.

    Frontiers in pediatrics 2021; (9()):673957 doi:10.3389/fped.2021.673957.

    PMID: 34095032
  25. 25

    Familial hemophagocytic lymphohistiocytosis syndrome due to lysinuric protein intolerance: a patient with a novel compound heterozygous pathogenic variant in SLC7A7.

    Matsukawa Y, Sakamoto K, Ikeda Y, et al.

    International journal of hematology 2022; (116(4)):635-638 doi:10.1007/s12185-022-03375-z.

    PMID: 35532875
  26. 26

    Nonhepatic Hyperammonemia With Septic Shock: Case and Review of Literature.

    Dalsania N, Kundu S, Patti RK, et al.

    Journal of investigative medicine high impact case reports 2022; (10()):23247096221101855 doi:10.1177/23247096221101855.

    PMID: 35596541
  27. 27

    Children with lysinuric protein intolerance: Experience from a lower middle income country.

    Hashmi SB, Ahmed S

    World journal of clinical pediatrics 2022; (11(4)):369-374 doi:10.5409/wjcp.v11.i4.369.

    PMID: 36052112
  28. 28

    Improving a Rare Metabolic Disorder Through Kidney Transplantation: A Case Report of a Patient With Lysinuric Protein Intolerance.

    IJzermans T, van der Meijden W, Hoeks M, et al.

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2023; (81(4)):493-496 doi:10.1053/j.ajkd.2022.08.019.

    PMID: 36223829
  29. 29

    Delayed skeletal development and IGF-1 deficiency in a mouse model of lysinuric protein intolerance.

    Stroup BM, Li X, Ho S, et al.

    Disease models & mechanisms 2023; (16(8)) doi:10.1242/dmm.050118.

    PMID: 37486182
  30. 30

    Lysinuric protein intolerance presenting as pancytopenia and splenomegaly mimicking acute leukaemia: a case report.

    Lokuhewage C, Pathiraja H, Madawala P, et al.

    BMC pediatrics 2023; (23(1)):382 doi:10.1186/s12887-023-04207-7.

    PMID: 37528333
  31. 31

    A complicated case of whole-lung lavage: a case report.

    Petrarulo S, Lucchin M, Oldani S, et al.

    Frontiers in medicine 2023; (10()):1225167 doi:10.3389/fmed.2023.1225167.

    PMID: 37538311
  32. 32

    Lysinuric protein intolerance caused by a homozygous SLC7A7 deletion and presented with hyperferritinemia and osteoporosis in two siblings.

    Kalay I, Aykut H, Caliskan Z, et al.

    Molecular genetics and metabolism reports 2023; (37()):101022 doi:10.1016/j.ymgmr.2023.101022.

    PMID: 38053936
  33. 33

    [Enteral nutrition support for lysinuric protein intolerance: a case report and literature review].

    Quan J, Liu XF, Hu K, Hou Q

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2023; (25(12)):1270-1275 doi:10.7499/j.issn.1008-8830.2306148.

    PMID: 38112146
  34. 34

    A novel variant in a Chinese boy with lysinuric protein intolerance: A case report and literature review.

    Wang Y, Li H, Huang Z, et al.

    Heliyon 2024; (10(5)):e27044 doi:10.1016/j.heliyon.2024.e27044.

    PMID: 38444501
  35. 35

    Meaning-Making Among Parents of Children With Severe Neurologic Impairment in the PICU.

    Bogetz JF, Oslin E, O'Donnell M, et al.

    Pediatrics 2024; (153(4)) doi:10.1542/peds.2023-064361.

    PMID: 38529567
  36. 36

    The Great Masquerade: Varying Manifestations of Lysinuric Protein Intolerance.

    Chakraborty S, Kaur R, Patra B, et al.

    Indian journal of pediatrics 2025; (92(1)):70-72 doi:10.1007/s12098-024-05124-y.

    PMID: 38703326
  37. 37

    Survey of patient satisfaction with genetic counseling services in Korea.

    Choi IH, Kim YK, Yang SY, et al.

    Journal of genetic counseling 2025; (34(1)):e1922 doi:10.1002/jgc4.1922.

    PMID: 38769825
  38. 38

    Title not available

    Jbebli E, Jbeli Y, Amdouni R, et al.

    La Tunisie medicale 2024; (102(5)):284-288 doi:10.62438/tunismed.v102i5.4792.

    PMID: 38801286
  39. 39

    Whole lung lavage and GM-CSF use for pulmonary alveolar proteinosis in an infant with lysinuric protein intolerance: a case report.

    Vojcek E, Krikovszky D, Lódi C, et al.

    Italian journal of pediatrics 2024; (50(1)):111 doi:10.1186/s13052-024-01677-y.

    PMID: 38831374
  40. 40

    Lysinuric Protein Intolerance: Not Only a Disorder for Pediatric Nephrologists - Case Report.

    Rigoldi M, Mele C, Breno M, et al.

    Nephron 2025; (149(2)):116-124 doi:10.1159/000541363.

    PMID: 39293417
  41. 41

    Compensation for metabolic dietitians practicing in the United States: 2023 genetic metabolic dietitians international professional status survey.

    Viau K, Gaughan S, Kopesky J, et al.

    Molecular genetics and metabolism reports 2024; (41()):101147 doi:10.1016/j.ymgmr.2024.101147.

    PMID: 39399387
  42. 42

    Assessing and attending to psychosocial concerns in genetic counseling: Proposing the BATHE method.

    Moscarello T, Higgs E, Pollard E, et al.

    Journal of genetic counseling 2025; (34(3)):e1998 doi:10.1002/jgc4.1998.

    PMID: 39535335
  43. 43

    Outcomes of kidney transplantation in patients with lysinuric protein intolerance.

    Rautanen T, Ahopelto K, Niinikoski H, et al.

    Clinical kidney journal 2025; (18(1)):sfae373 doi:10.1093/ckj/sfae373.

    PMID: 39802587
  44. 44

    Interstitial Lung Disease in Lysinuric Protein Intolerance Diagnosed by a Transbronchial Lung Cryobiopsy.

    Ono M, Abe M, Saiki A, et al.

    Internal medicine (Tokyo, Japan) 2025; (64(15)):2375-2381 doi:10.2169/internalmedicine.4074-24.

    PMID: 39894503
  45. 45

    Dual pathogenic mechanisms in lysinuric protein intolerance: Interplay between hyperammonemia and cellular metabolic dysregulation in astrocyte injury.

    Kakisaka K, Sato T, Wada Y, et al.

    Molecular genetics and metabolism 2025; (145(2)):109134 doi:10.1016/j.ymgme.2025.109134.

    PMID: 40349487
  46. 46

    Caregiver burden in family caregivers of individuals with cancer in Iran: an analytical cross-sectional study.

    Mirshahi A, Farsi Z, Sajadi SA, et al.

    Journal of health, population, and nutrition 2025; (44(1)):186 doi:10.1186/s41043-025-00929-9.

    PMID: 40468411
  47. 47

    Lysinuric protein intolerance: Unusual clinical manifestations in a compound heterozygote with a novel pathogenic variant.

    Pascual López JR, Wu W, Konczal L

    Biochemistry and biophysics reports 2025; (44()):102229 doi:10.1016/j.bbrep.2025.102229.

    PMID: 41189639
  48. 48

    Lysinuric protein intolerance: Allogeneic peripheral blood stem cell transplantation for an inborn error of metabolism and immunity.

    Zubarovskaya N, Mayr JA, Aigner E, et al.

    Molecular genetics and metabolism 2025; (147(1)):109688 doi:10.1016/j.ymgme.2025.109688.

    PMID: 41337869
  49. 49

    Monogenic lupus with SLC7A7 mutations: a retrospective study from a Chinese center.

    Li Y, Lv Q, Lu W, et al.

    Orphanet journal of rare diseases 2026; (21(1)).

    PMID: 41821046